APA (7th ed.) Citation

L, R., V, G., A, M., FM, S., V, S., A, C., . . . L, D. L. (2026). Efficacy of PCSK9 Inhibitors on Clinical Outcomes in Patients with Established Atherosclerotic Cardiovascular Disease: A Network Meta-analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions, 26(2), 193. https://doi.org/10.1007/s40256-025-00778-1

Chicago Style (17th ed.) Citation

L, Raone, Gritti V, Mandurino-Mirizzi A, Sparasci FM, Scotti V, Currao A, Colonna G, Ferlini M, and De Luca L. "Efficacy of PCSK9 Inhibitors on Clinical Outcomes in Patients with Established Atherosclerotic Cardiovascular Disease: A Network Meta-analysis." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 26, no. 2 (2026): 193. https://doi.org/10.1007/s40256-025-00778-1.

MLA (9th ed.) Citation

L, Raone, et al. "Efficacy of PCSK9 Inhibitors on Clinical Outcomes in Patients with Established Atherosclerotic Cardiovascular Disease: A Network Meta-analysis." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions, vol. 26, no. 2, 2026, p. 193, https://doi.org/10.1007/s40256-025-00778-1.